The black box warning for topical calcineurin inhibitors: looking outside the box

Ann Allergy Asthma Immunol. 2006 Jul;97(1):117-20. doi: 10.1016/S1081-1206(10)61381-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Adult
  • Adverse Drug Reaction Reporting Systems
  • Allergy and Immunology
  • Attitude of Health Personnel
  • Attitude to Health
  • Causality
  • Child
  • Dermatitis, Atopic / drug therapy
  • Drug Labeling*
  • Fear
  • Humans
  • Lymphoma / chemically induced
  • Lymphoma / epidemiology
  • Lymphoproliferative Disorders / chemically induced
  • Neoplasms / chemically induced*
  • Neoplasms / epidemiology
  • Patient Acceptance of Health Care
  • Patients / psychology
  • Physicians / psychology
  • Quality of Life
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / epidemiology
  • Societies, Medical
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects*
  • Tacrolimus / analogs & derivatives*
  • Tacrolimus / pharmacology
  • Tacrolimus / therapeutic use

Substances

  • pimecrolimus
  • Tacrolimus